Clinical Trials Directory

Trials / Completed

CompletedNCT00712036

Entry Into Comprehensive Methadone Treatment Via Interim Maintenance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
230 (actual)
Sponsor
Friends Research Institute, Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine whether one of three levels of counseling intensity will be associated with better treatment outcomes when combined with methadone maintenance treatment for heroin-addicted adults drawn from a methadone treatment program waiting list.

Detailed description

Waiting lists for methadone treatment programs persist, and new and more effective approaches for expanding treatment access and improving outcomes for heroin dependent individuals are needed. Recently completed research demonstrated that so-called "Interim Methadone Maintenance" (i.e., methadone with crisis counseling only, for individuals on waiting lists) was associated with greater entry into methadone treatment, less self-reported heroin and cocaine use, lower rates of opioid-positive drug tests, and lower rates of self-reported crime. The present study will build on this work by comparing three levels of counseling provided with methadone treatment: 1)"Interim" Methadone Treatment; 2) "Comprehensive" Methadone Treatment (which is the name for the usual amount of counseling provided, i.e., about once per week) and; 3)"Restored" Methadone Treatment in which the counselors will have a lower case load and will be able to provide more attention to their patients.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInterimMethadone maintenance with emergency counseling only for up to 4 months
BEHAVIORALComprehensiveMethadone treatment with counseling as usual
BEHAVIORALRestoredMethadone maintenance with counseling provided by a clinician with a lower than usual caseload

Timeline

Start date
2008-06-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2008-07-09
Last updated
2015-01-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00712036. Inclusion in this directory is not an endorsement.